CL
BMRN icon

Choreo LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Choreo LLC’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Buy
10,897
+415
+4% +$22.7K 0.01% 871
2026
Q1 		$592K Buy
10,482
+5,181
+98% +$302K 0.01% 848
2025
Q4 		$313K Sell
5,301
-1,566
-23% -$85.3K ﹤0.01% 1193
2025
Q3 		$372K Sell
6,867
-406
-6% -$23.2K ﹤0.01% 1098
2025
Q2 		$400K Buy
7,273
+464
+7% +$27.3K 0.01% 1015
2025
Q1 		$481K Sell
6,809
-3,225
-32% -$217K 0.01% 853
2024
Q4 		$657K Sell
10,034
-214
-2% -$14.3K 0.01% 761
2024
Q3 		$718K Buy
10,248
+1,572
+18% +$131K 0.01% 721
2024
Q2 		$713K Buy
+8,676
New +$722K 0.01% 656

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Choreo LLC's BMRN Position: Q2 2026 in Review

Choreo LLC increased its BioMarin Pharmaceuticals (BMRN) stake by 4% in Q2 2026, buying an estimated $22.7K and bringing the position to 10,897 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #871.

Choreo LLC first reported a position in BMRN in Q2 2024 and has held it in 9 quarters since. The position peaked at $718K in Q3 2024. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Choreo LLC held 10,897 shares of BioMarin Pharmaceuticals worth $624K as of Q2 2026.
  • Choreo LLC bought 415 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $22.7K.
  • BioMarin Pharmaceuticals made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #871 holding.
  • Choreo LLC first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's BioMarin Pharmaceuticals position peaked at $718K in Q3 2024.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.